Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

NCT00321984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

947

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Dexlansoprazole MR
DRUG: Dexlansoprazole MR
DRUG: Placebo

Sponsor

Takeda